2018-21354. Importer of Controlled Substances Registration  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

    End Preamble Start Supplemental Information Start Printed Page 49580

    SUPPLEMENTARY INFORMATION:

    The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices are listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

    CompanyFR DocketPublished
    AMRI Rensselaer, Inc83 FR 15176April 9, 2018.
    S&B Pharma, Inc83 FR 31421July 5, 2018.
    Cerilliant Corporation83 FR 32906July 16, 2018.
    Shertech Laboratories, LLC83 FR 34879July 23, 2018.
    Fresenius Kabi USA, LLC83 FR 34878July 23, 2018.
    VHG Labs DBA LGC Standards83 FR 34875July 23, 2018.
    Catalent Pharma Solutions, LLC83 FR 34874July 23, 2018.
    Fisher Clinical Services, Inc83 FR 34879July 23, 2018.
    Anderson Brecon, Inc83 FR 37525August 1, 2018.

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971.

    The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.

    Start Signature

    Dated: September 20, 2018.

    John J. Martin,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2018-21354 Filed 10-1-18; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
10/02/2018
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2018-21354
Pages:
49579-49580 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2018-21354.Pdf